Solving Bioavailability Challenges

E.SOLVE

Challenging API?

With E.SOLVE, we take the time to thoroughly and carefully understand your API's physicochemical profile and bioavailability needs, combining data and expertise to create a panel of formulations and testing for the optimal results.

E.SOLVE accelerates your journey to the clinic supporting as early as possible your formulation strategy from discovery to market approval.

RZ E SOLVE Logo Tagline 211004 Screen Blue png

Enhanced Formulation For Improved Bioavailability

E.SOLVE includes a full range of approaches to improve solubility and bioavailability from solubilization, solid state modification, amorphous solid dispersion, particle size reduction, and permeation enhancement.

Faster Progression Towards Clinical Answers Through:

  • A holistic approach to smart screening
  • Formulation strategy driven by molecule physico-chemical properties
  • Limited amount of API required
  • Quick delivery of fit for purpose formulations
  • Rapid access to in vivo verification
  • Integrated multidisciplinary approach to de-risk strategy
  • End-to-end support for preclinical and clinical development
  • Complete flexibility to fit your project goal

Contact Our Experts

Emanuela Del Vesco

Emanuela Del Vesco

EVP Head of Global Pharmaceutical Development & Manufacturing

vCard
Logo Evotec white
Evotec has the right technologies & disease understanding to meet our partners' evolving needs: a comprehensive disease knowledge at the molecular level, cutting-edge technologies & platforms to translate this expertise into effective precision medicines.